| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260269.1 |
Docetaxel |
Chronic Lymphocytic Leukemia |
0.016267062 |
Resistant |
| ENSG00000260269.1 |
Docetaxel |
Brain lower grade glioma |
0.010105586 |
Resistant |
| ENSG00000260269.1 |
Docetaxel |
Bladder urothelial carcinoma |
0.014017739 |
Sensitive |
